openPR Logo
Press release

Gastric Cancer Market Size Forecasted To Achieve 6.43 Billion By 2029 With Steady Growth

06-16-2025 08:26 AM CET | Health & Medicine

Press release from: The Business Research Company

Gastric Cancer Market

Gastric Cancer Market

Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What Is the Gastric Cancer Market Size and Projected Growth Rate?
The market size of gastric cancer has seen a swift expansion in the last few years. It is projected to expand from $3.17 billion in 2024 to $3.65 billion in 2025, maintaining a compound annual growth rate (CAGR) of 15.4%. Factors such as the increase in the elderly population, enhanced healthcare awareness, a surge in genetic mutations, the rise in unhealthy lifestyle practices, and increased cancer awareness, contributed to the growth during the historic period.

In the coming years, the market size for gastric cancer is predicted to witness a swift expansion. It is estimated to reach $6.43 billion by 2029 with a compound annual growth rate (CAGR) of 15.2%. Factors contributing to the growth during this forecasted period include a rise in obesity rates, escalating governmental initiatives, burgeoning investments in healthcare, an enhanced demand for oral drugs, and the increase in cancer treatment centers. The forecast period is also characterized by notable trends such as combined chemotherapy, product diversification, operations assisted by robots, focus on targeted therapies, strategic partnerships, and the utilization of more advanced diagnostic tools.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20797

What Are the Major Segments in the Gastric Cancer Market?
The gastric cancer market covered in this report is segmented -

1) By Type: Adenocarcinoma, Lymphoma, Gastrointestinal Stromal Tumor, Carcinoid Tumor, Other Types
2) By Diagnosis: Endoscopy, Biopsy, Imaging Tests, Exploratory Surgery, Other Diagnosis
3) By Treatment: Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Palliative Care, Other Treatments
4) By Distribution Channel: Hospital Pharmacies, Specialty And Retail Pharmacies, Other Distribution Channels

Subsegments:
1) By Adenocarcinoma: Intestinal Type Adenocarcinoma, Diffuse Type Adenocarcinoma, Mixed Type Adenocarcinoma
2) By Lymphoma: Primary Gastric Lymphoma, Secondary Gastric Lymphoma
3) By Gastrointestinal Stromal Tumor (GIST): Primary GIST, Metastatic GIST
4) By Carcinoid Tumor: Gastric Carcinoid Type 1, Gastric Carcinoid Type 2, Gastric Carcinoid Type 3
5) By Other Types: Small Cell Carcinoma, Squamous Cell Carcinoma, Mixed Tumors

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20797&type=smp

What Are The Driving Gastric Cancer Market Evolution?
The swelling numbers of obesity are anticipated to stimulate the expansion of the gastric cancer market. Defined by a body mass index (BMI) of 30 or above, obesity is a health condition characterized by an abnormal accumulation of body fat, which can result in numerous health complications. The increase in obesity rates can be attributed to elements such as unhealthy eating habits, insufficient physical exercise, inactive lifestyles, environmental variables, and genetic susceptibilities. Excessive body fat, especially intra-abdominal fat, is linked to an elevated risk of gastric cancer because it instigates chronic inflammation and metabolic disruptions, both of which are connected to cancer progression. This, in turn, fuels the need for gastric cancer treatment. As an example, the World Health Organization, an intergovernmental organization based in Switzerland, disclosed in March 2024 that roughly one in eight people worldwide in 2022 were obese, with 2.5 billion adults aged 18 and older categorized as overweight. This figure includes 890 million people affected by obesity. Among adults, 43% were overweight, and 16% were obese. Moreover, 37 million children below the age of five were overweight, and over 390 million children and adolescents between 5 and 19 years old were overweight, including 160 million living with obesity. Consequently, the escalating obesity rates are fueling the gastric cancer market.

Which Firms Dominate The Gastric Cancer Market Segments?
Major companies operating in the gastric cancer market are F. Hoffmann La Roche Ltd., Merck And Co. Inc., AbbVie Inc., Sanofi S.A., Bristol Myers Squibb Company, Abbott Laboratories, Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim, Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Ipsen Biopharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Samsung Biologics Co. Ltd., Celltrion Healthcare Co. Ltd., Biocon Limited, Hanmi Pharmaceuticals, Mylan N.V., Taiho Oncology Inc., Hikma Pharmaceuticals PLC, Taiho Pharmaceuticals Co. Ltd., AROG Pharmaceuticals Inc.

What Trends Are Expected to Dominate the Acquired Autoimmune Hemolytic Anemia Market in the Next 5 Years?
Leaders in the gastric cancer market are concentrating on the development of technologically sophisticated solutions including companion diagnostic assays to facilitate individualized treatment plans. These assays are tests designed to pinpoint patients likely to respond positively to a specific therapeutic intervention, by detecting specific biomarkers. For instance, in October 2024, Swiss pharmaceutical corporation F. Hoffmann-La Roche Ltd., received US FDA approval for the VENTANA CLDN18 (43-14A) RxDx Assay. This assay happens to be the first immunohistochemistry (IHC) companion diagnostic serving to evaluate CLDN18 protein expression in gastric and gastroesophageal junction (GEJ) adenocarcinoma. This assay identifies patients suitable for targeted treatment with VYLOY (zolbetuximab) by recognizing CLDN18 protein variants, primarily CLDN18.2. These assays, used with the OptiView DAB IHC Detection Kit on the BenchMark ULTRA instrument, push forward personalized medicine and widen the range of treatment alternatives for gastric and GEJ adenocarcinoma.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/gastric-cancer-global-market-report

Which Is The Largest Region In The Gastric Cancer Market?
North America was the largest region in the gastric cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Gastric Cancer Market?
2. What is the CAGR expected in the Gastric Cancer Market?
3. What Are the Key Innovations Transforming the Gastric Cancer Industry?
4. Which Region Is Leading the Gastric Cancer Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gastric Cancer Market Size Forecasted To Achieve 6.43 Billion By 2029 With Steady Growth here

News-ID: 4067457 • Views:

More Releases from The Business Research Company

Role Of Mobile App Optimization In Social Media Growth: An Emerging Driver Transforming The Mobile Application Optimization Software Market Landscape
Role Of Mobile App Optimization In Social Media Growth: An Emerging Driver Trans …
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics. What Is the Projected Growth of the Mobile Application Optimization Software Market? The market size for software that optimizes mobile applications has experienced rapid growth in the past few years. It is projected to increase from $1.58 billion in 2024 to $1.85 billion in 2025, representing a compound annual growth rate (CAGR) of 17.3%.
Global Privigen Market Outlook 2025-2034: Drivers, Innovations, And Future Outlook
Global Privigen Market Outlook 2025-2034: Drivers, Innovations, And Future Outlo …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries. How Big Is the Privigen Market Size Expected to Be by 2034? In recent years, the Privigen market has seen a XX (HCAGR) upswing. The market is anticipated to expand from $XX million in 2024 to $XX million in 2025, demonstrating a Compound Annual Growth Rate (CAGR) of XX%. This vigorous growth
Metaverse In Automotive Market Size Forecasted To Achieve 17.65 Billion By 2029 With Steady Growth
Metaverse In Automotive Market Size Forecasted To Achieve 17.65 Billion By 2029 …
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics. What Is the Metaverse In Automotive Market Size and Projected Growth Rate? The size of the automotive metaverse market has seen an exponential increase in recent years, and it is expected to expand from $4.03 billion in 2024 to $5.43 billion in 2025, with a compound annual growth rate (CAGR) of 34.6%. This notable
Emerging Trends Influencing The Growth Of The Vpriv Market: Strategic Investments Driving Growth And Expansion In The Zolgensma Market
Emerging Trends Influencing The Growth Of The Vpriv Market: Strategic Investment …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries. How Big Is the Vpriv Market Size Expected to Be by 2034? In recent times, the market size for vpriv has seen a XX (HCAGR) surge. The market value is set to increase from $XX million in 2024, growing to $XX million in 2025 with a compound annual growth rate (CAGR) of

All 5 Releases


More Releases for Gastric

Gastric Balloon Market: Global Industry Analysis Report 2018
The Gastric Balloon market was valued at Million US$ in 2017 and is projected to reach Million US$ by 2025, at a CAGR of during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Gastric Balloon. This study focuses on the production side and consumption side of Gastric Balloon, presents the global
The Virtual Gastric Band 101
There’s been a lot in the media recently about the Hypnotic Gastric Band or also known as The Virtual Gastric Band. I get asked a lot about it so thought I’d give a Virtual Gastric Band 101 on what it is, but more importantly what it’s not. ​The Virtual Gastric Band - It is a non-surgical technique which uses the power of hypnosis to retrain the person to be satisfied with smaller
Coastal Cosmetics Reshape Gastric Balloon Webinar
Those who are in the dieting industry and related fields, as well as professional medical clinicians, know that weight loss is a hard and complex struggle. In many cases, weight loss is the best way to deal with chronic conditions and prevent major health threats, even those that can be potentially fatal. At the same time, lifestyle changes may not accomplish the results that a patient needs. The Reshape gastric balloon
Global Gastric Ulcers Therapeutic Pipeline Review, H2 2017
"The Report Gastric Ulcers - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastric Ulcers - Pipeline Review, H2 2017, provides an overview of the Gastric Ulcers (Gastrointestinal) pipeline landscape. Gastric ulcer is a painful sore or ulcer in the lining of stomach. The most common cause of
BRIC Bariatric Surgery Devices Market Segments - Bariatric Stapling Devices, Gas …
"The Report BRIC Bariatric Surgery Devices Market Outlook to 2023 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" GlobalDatas new report, "BRIC Bariatric Surgery Devices Market Outlook to 2023", provides key market data on the BRIC Bariatric Surgery Devices market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments -
Global Gastric Banding Market Research Report 2017
This report studies Gastric Banding in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering Roche Abbott Siemens Alere Nova Request Sample Report: http://www.reportbazzar.com/request-sample/?pid=887564&ptitle=Global+Gastric+Banding+Market+Research+Report+2017&req=Sample Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Gastric Banding in these regions, from 2011 to 2021